Discordance between increase in billed procedures vs increase in number of patients.
Topical vitamin A provides no benefit in treating atopic dermatitis, whereas topical vitamin D may actually exacerbate symptoms, according to an evidence-based review.
The biologic dupilumab is projected to be a cost-effective treatment for moderate-to-severe atopic dermatitis, shows a new study. (©Dzm1try/Shutterstock.com)
When it comes to successfully diagnosing melanonychia ― a brown or black pigmentation of the nail unit – it is important to examine the nails, look for pigmented lesions, be suspicious of nail melanoma, and biopsy early rather than late.
Study shows that blocking IL-13 improves atopic dermatitis ― a promising finding for IL-13 atopic dermatitis drugs in development.
Mapping the human genome for chronic itch holds the potential to develop targeted therapy for atopic dermatitis and psoriasis itch, a study shows.
The Food and Drug Administration is in the process of evaluating scientific data on the safety of probiotics and postbiotics in cosmetics, said Linda Katz, M.D., director of the Office of Cosmetics and Color for the FDA.
In speaking at the 2018 AAD Summer Meeting in Chicago, one doctor recommends that dermatologists in training learn more about diagnosing and treating STDs due to increasing prevalence.
Patients with moderate-severe atopic dermatitis are at high risk of having inadequate disease control, according to a cross-sectional study in JAMA Dermatology.
Study finds the combination of duplilumab and topical corticosteroids works in hard-to-treat atopic dermatitis cases in adult patients.